Tech Company Financing Transactions

Exuma Biotech Funding Round

Exuma Biotech closed a $19 million Series B venture capital round on 3/13/2020. Investors included F1 BioVentures and MSD Capital.

Transaction Overview

Company Name
Announced On
3/13/2020
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to advance new logic gated CAR-T therapies for solid tumor malignancies as well as for further development and partnering of its rapid point-of-care (or rPOC), same-day CAR-T platform technology.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
625 N. Flagler Dr. 625
West Palm Beach, FL 33401
USA
Email Address
Overview
EXUMA Biotechnology's mission is to provide lasting remissions via cellular therapies for patients with no other options. We are driven to achieve clinically relevant reductions in cancer mortality through industrial innovation and scientific integrity, while generating accessible solutions for patients around the world.
Profile
Exuma Biotech LinkedIn Company Profile
Social Media
Exuma Biotech Company Twitter Account
Company News
Exuma Biotech News
Facebook
Exuma Biotech on Facebook
YouTube
Exuma Biotech on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Gregory Frost
  Gregory Frost LinkedIn Profile  Gregory Frost Twitter Account  Gregory Frost News  Gregory Frost on Facebook
Chief Financial Officer
James Samuels
  James Samuels LinkedIn Profile  James Samuels Twitter Account  James Samuels News  James Samuels on Facebook
Vice President
Bruce Yan
  Bruce Yan LinkedIn Profile  Bruce Yan Twitter Account  Bruce Yan News  Bruce Yan on Facebook
VP - Human Resources
Diane McCarty
  Diane McCarty LinkedIn Profile  Diane McCarty Twitter Account  Diane McCarty News  Diane McCarty on Facebook
VP - Operations
Wendy Zhang
  Wendy Zhang LinkedIn Profile  Wendy Zhang Twitter Account  Wendy Zhang News  Wendy Zhang on Facebook
VP - Product Management
Alissa Kerner
  Alissa Kerner LinkedIn Profile  Alissa Kerner Twitter Account  Alissa Kerner News  Alissa Kerner on Facebook
VP - R & D
Leon Zong
  Leon Zong LinkedIn Profile  Leon Zong Twitter Account  Leon Zong News  Leon Zong on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/13/2020: Kymera Therapeutics venture capital transaction
Next: 3/13/2020: Nurix Therapeutics venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary